BeyondSpring Inc (BYSI)
Healthcare
Biotechnology
1.20 $
+1.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns BeyondSpring Inc (BYSI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.7% of the shares are freely tradable; institutional investors hold 14.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
14.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
14.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
77.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
41Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Decheng Capital LLC | 9.24 | 3,800,702 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 1.85 | 758,953 | +38.8 | 12/31/2025 |
| BlackRock Inc | 1.58 | 649,462 | -3.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.48 | 607,934 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.91 | 375,371 | +1.8 | 03/31/2026 |
| State Street Corp | 0.56 | 231,120 | +0.0 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.44 | 179,925 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 0.84 | 344,384 | +0.0 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 0.64 | 263,550 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.40 | 164,922 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.